Why MBiotech?


Why MBiotech?

MBiotech is an innovative, professional Master's degree program that provides students with a world class graduate education in the biotech, medical device and biopharmaceutical industries.

As an MBiotech student, you will complete 8-12 months of paid industry internships. Our industry partners are world leaders, including Amgen, AstraZeneca, GlaxoSmithKline, Roche, Sanofi Pasteur and many others. See a list of our internship partners.

In addition to the paid internship, you will have the opportunity to work on a broad scope of projects as part of your core courses, many of these in partnership with industry and leading teaching hospitals. Learn more about student projects

The carefully selected combination of courses, coupled with relevant industry experience and a strong focus on team work, provides our graduates with a truly interdisciplinary educational experience at a world-renowned university.

Our students place very well in competitions, such as the Venture Capital & Innovation Competition and the GSK international essay competition.

You will have a wide range of opportunities available to you upon graduation. Browse through some current student profiles or alumni profiles

Our most recent employment survey, conducted for the Class of 2014, showed that 100 percent of graduates found related work in industry within 6 months of graduation, and 80 percent of our students secured full-time positions even before officially graduating!

For more information, please email mbiotech@utoronto.ca or call us at 905-569-4737.

Life Sciences in Ontario 

Ontario is the largest life sciences jurisdiction in Canada with approximately 50% of the total Canadian life sciences economic activity, and employing about 38,000 people. 

More specifically, the Pharmaceutical and Biotechnology Sector in Ontario employs approximately 15,000 people in about 110 companies such as GlaxoSmithKline, Apotex, Roche, Sanofu Pasteur, etc. In fact, Ontario ranks third in North America in terms of the number of pharmaceutical and medical manufacturing establishments.

Ontario's life science sector accounts for about 58% of Canadian R&D life science spending, exports about $5.2 billion in goods a year and accounts for over half of Canada's patents from 2005-2010.

Source: Government of Ontario: Life Sciences Key Facts, 2013.